Kim, M. Imakura and J. McLarnan for expert technical assistance, M. Biery for assistance with computer graphics and the Rosetta Gene Expression Laboratory for microarray work. You can also search for this author in PubMed Google Scholar.
Reprints and Permissions. Jackson, A. Expression profiling reveals off-target gene regulation by RNAi. Nat Biotechnol 21, — Download citation. Received : 10 February Accepted : 18 March Published : 18 May Issue Date : 01 June Anyone you share the following link with will be able to read this content:.
Sorry, a shareable link is not currently available for this article. Provided by the Springer Nature SharedIt content-sharing initiative. Genome Biology Nature Reviews Drug Discovery Oncogene Nature Reviews Genetics Molecular Psychiatry Advanced search.
Skip to main content Thank you for visiting nature. Andrew Fire et al. RNAi induction using siRNAs or their biosynthetic precursors Transfection of an exogenous siRNA can be problematic, since the gene knockdown effect is only transient, particularly in rapidly dividing cells.
One way of overcoming this challenge is to modify the siRNA in such a way as to allow it to be expressed by an appropriate vector, e. This is done by the introduction of a loop between the two strands, thus producing a single transcript, which can be processed into a functional siRNA. It is assumed although not known for certain that the resulting siRNA transcript is then processed by Dicer. Structure Each strand has a 5' phosphate group and a 3' hydroxyl -OH group.
Essentially any gene of which the sequence is known can thus be targeted based on sequence complementarity with an appropriately tailored siRNA. This has made siRNAs an important tool for gene function and drug target validation studies in the post-genomic era! The effects of RNA interference can be both systemic and heritable in plants and C. In plants, RNAi is thought to propagate by the transfer of siRNAs between cells through plasmodesmata channels in the cell walls that enable communication and transport.
The heritability comes from methylation of promoters targeted by RNAi; the new methylation pattern is copied in each new generation of the cell.
A broad general distinction between plants and animals lies in the targeting of endogenously produced miRNAs; in plants, miRNAs are usually perfectly or nearly perfectly complementary to their target genes and induce direct mRNA cleavage by RISC, while animals' miRNAs tend to be more divergent in sequence and induce translational repression. This translational effect may be produced by inhibiting the interactions of translation initiation factors with the messenger RNA's polyadenine tail.
Some eukaryotic protozoa such as Leishmania major and Trypanosoma cruzi lack the RNAi pathway entirely. Most or all of the components are also missing in some fungi, most notably the model organism Saccharomyces cerevisiae. Certain ascomycetes and basidiomycetes are also missing RNA interference pathways; this observation indicates that proteins required for RNA silencing have been lost independently from many fungal lineages, possibly due to the evolution of a novel pathway with similar function, or to the lack of selective advantage in certain niches.
However these regulatory RNAs are not generally considered to be analogous to miRNAs because the dicer enzyme is not involved. Illustration of the major differences between plant and animal gene silencing. RNA interference RNAi , an accurate and potent gene-silencing method, was first experimentally documented in in Caenorhabditis elegans by Fire et al. RNAi offers researchers an effortless tool for investigating biological systems by selectively silencing genes.
Key technical aspects--such as optimization of selectivity, stability, in vivo delivery, efficacy, and safety--need to be investigated before RNAi can become a successful therapeutic strategy. Nevertheless, this area shows a huge potential for the pharmaceutical industry around the globe.
Interestingly, recent studies have shown that the small RNA molecules, either indigenously produced as microRNAs miRNAs or exogenously administered synthetic dsRNAs, could effectively activate a particular gene in a sequence-specific manner instead of silencing it.
The C. Small, noncoding RNAs have proven to be valuable tools for studying the roles of specific proteins in the cell.
When certain sequences are used to target specific genes, thus shutting off expression of the protein product, the effects of the deficiencies on the body can be observed.
This approach is being used to study the effects of abnormal RNAi expression on fetal development. Medical researchers are also studying ways to control expression of different proteins linked to various diseases by injecting manufactured dsRNA or antisense siRNA strands into cells Whalley, However, manipulating these different forms of RNA to effectively reduce gene expression is not always so easy.
Investigators have suggested that there are at least eight different steps to the algorithm for designing the most effective RNAi molecules to use in order to reduce expression Reynolds et al. Interestingly, many of the elements that need to be considered for optimization are a direct reflection of what we know about how RNAi works—including recognition and degradation of the target mRNA and interaction between the siRNA and RISC. Information provided by studies such as these may lead to the development of drugs to treat the inappropriate expression of certain genes, or perhaps to development of RNA-injection therapies for commercially important plants and for human and animal diseases.
Already, efforts are underway to use small, noncoding RNAs for treatment of a wide array of diseases including cancer , heart disease, and various infectious diseases Boyd, For example, a number of studies have indicated that small RNAs can act as tumor suppressors in the treatment of cancer.
However, there is also evidence that some miRNAs can act as oncogenes Boyd, It is clear that there is still a lot to learn about the hundreds of small RNAs in our bodies and what roles they play in gene expression.
Bernstein, E. Dicer is essential for mouse development Nature Genetics 35 , — doi Boyd, S. Everything you wanted to know about small RNA but were afraid to ask.
Laboratory Investigation 88 , — doi Buchan, J. The two faces of miRNA. Science , — doi Chen, K. The evolution of gene regulation by transcription factors and microRNAs. Nature Reviews Genetics 8 , 93— doi Heinrichs, A. Nature Reviews Molecular Cell Biology 5 , doi Kloc, A. Current Biology 18 , Lee, R.
The C. Cell 75 , — doi Reynolds, A. Rational design for RNA interference. Nature Biotechnology 22 , — doi Sadava, D. Freeman, Sijen, T. Cell , — doi Whalley, K. Nature Reviews Genetics 7 , doi Wilkins, C. RNA interference is an antiviral defense mechanism in Caenorhabditis elegans. Nature Letters , — doi Atavism: Embryology, Development and Evolution.
Gene Interaction and Disease. Genetic Control of Aging and Life Span. Genetic Imprinting and X Inactivation. Genetic Regulation of Cancer. Obesity, Epigenetics, and Gene Regulation. Environmental Influences on Gene Expression.
Gene Expression Regulates Cell Differentiation. Genes, Smoking, and Lung Cancer. Negative Transcription Regulation in Prokaryotes.
0コメント